Stock comparison
JOHNSON & JOHNSON is 80.5x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($655.15 B vs $8.14 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
JNJ is larger
JOHNSON & JOHNSON is 80.5x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($655.15 B vs $8.14 B).
Market value leader
JNJ
JOHNSON & JOHNSON is 80.5x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($655.15 B vs $8.14 B).
Revenue leader
JNJ
ARWR: $829.45M vs JNJ: $94.19B.
Profit leader
JNJ
ARWR: -$1.63M vs JNJ: $26.80B.
Margin leader
JNJ
ARWR: -0.2% vs JNJ: 28.5% net margin.
| Metric | ARWR | JNJ |
|---|---|---|
| Market cap | $8.14 B | $655.15 B |
| US-listed rank | #1037 | #17 |
| Revenue (latest FY) | $829.45M | $94.19B |
| Net income (latest FY) | -$1.63M | $26.80B |
| Net margin | -0.2% | 28.5% |
| P/E (trailing FY) | - | 24.4x |
| SEC filings | 1,343 | 1,004 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
JOHNSON & JOHNSON is 80.5x more valuable than ARROWHEAD PHARMACEUTICALS, INC. by market capitalization ($655.15 B vs $8.14 B).
In their latest fiscal years, ARROWHEAD PHARMACEUTICALS, INC. reported $829.45M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: ARROWHEAD PHARMACEUTICALS, INC. and JOHNSON & JOHNSON, or browse the full rankings.